Profil
Mark Sims is currently Chief Commercial Officer at Candel Therapeutics, Inc. Formerly, Mr. Sims was VP & Global Franchise Head-EGFRm Lung Cancer at AstraZeneca PLC.
Education includes an MBA from Thunderbird School of Global Management and an undergraduate degree from McMaster University.
Aktiva positioner av Mark Sims
| Företag | Position | Start |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Företagsledare/Principal | 2026-07-06 |
Tidigare kända positioner av Mark Sims
| Företag | Position | Slut |
|---|---|---|
| ASTRAZENECA PLC | Företagsledare/Principal | - |
Mark Simss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Kopplade företag
| Privata företag | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Thunderbird School of Global Management
Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
















